GGrantIndex
← Search

Leadership, Planning, and Evaluation

$186,453P30FY2024CANIH

Wake Forest University Health Sciences, Winston-Salem NC

Investigators

Linked publications, trials & patents

Trial NCT07614022Trial NCT07324577Trial NCT07322367Trial NCT07282444Trial NCT07203534Trial NCT07196241Trial NCT07175376Trial NCT07119489Trial NCT07046936Trial NCT06945042Trial NCT06709404Trial NCT06654245Trial NCT06480591Trial NCT06441266Trial NCT06340503Trial NCT05984680Trial NCT05934851Trial NCT05877404Trial NCT05854966Trial NCT05825066Trial NCT05796518Trial NCT05696782Trial NCT05692635Trial NCT05597878Trial NCT05395936Trial NCT05309655Trial NCT05242770Trial NCT05212272Trial NCT05204290Trial NCT05030038Trial NCT04897217Trial NCT04858269Trial NCT04797884Trial NCT04677816Trial NCT04659993Trial NCT04623515Trial NCT04586127Trial NCT04526080Trial NCT04495751Trial NCT04485026Trial NCT04454489Trial NCT04430335Trial NCT04415944Trial NCT04375384Trial NCT04337580Trial NCT04327700Trial NCT04266470Trial NCT04253964Trial NCT04217317Trial NCT04174742Trial NCT04173247Trial NCT04111107Trial NCT04040244Trial NCT04037527Trial NCT03998189Trial NCT03987568Trial NCT03987555Trial NCT03982537Trial NCT03963739Trial NCT03958747Trial NCT03929211Trial NCT03890614Trial NCT03880526Trial NCT03874065Trial NCT03870529Trial NCT03870451Trial NCT03868943Trial NCT03867175Trial NCT03861091Trial NCT03861065Trial NCT03796273Trial NCT03746262Trial NCT03741868Trial NCT03741829Trial NCT03740035Trial NCT03681405Trial NCT03662074Trial NCT03529565Trial NCT03520283Trial NCT03505762Trial NCT03505736Trial NCT03505671Trial NCT03379376Trial NCT03374995Trial NCT03370159Trial NCT03188432Trial NCT03152786Trial NCT03148080Trial NCT03139435Trial NCT03122743Trial NCT03087591Trial NCT03032250Trial NCT02971410Trial NCT02971397Trial NCT02949843Trial NCT02835222Trial NCT02835066Trial NCT02832154Trial NCT02827838Trial NCT02747407

Abstract

LEADERSHIP, PLANNING, AND EVALUATION (LPE): PROJECT SUMMARY The Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) Leadership, Planning, and Evaluation is an essential multi-level process that identifies strategic opportunities, performs ongoing evaluation, and develops Center initiatives. The Cancer Center Director establishes the vision for the WFBCCC with input from the Senior Leaders and feedback from the various planning and evaluation activities and committees. WFBCCC’s vision is to be a preeminent leader in advancing the understanding of cancer through research innovation, discovery, and translation into innovative therapies and prevention strategies through exemplary collaboration and community engagement. WFBCCC’s mission is to reduce cancer incidence, morbidity, and mortality along the rural southeast Appalachian region of the United States, as well as nationally and internationally, through cutting-edge research and treatment, community education and outreach, and transdisciplinary training of next-generation biomedical scientists and healthcare providers. Implementation is guided by a well-developed Strategic Plan, which was informed by Cancer Center stakeholders, including its advisory bodies, the Institution, the community, and Center members. Planning and evaluation activities address both the strategic priorities and Center operations. They also thoroughly assess program goals, transdisciplinary and translational research, community outreach and engagement, education and training development, strategic recruitment, pilot project support, the clinical trial portfolio, and accrual strategy. The strong commitment to planning and evaluation activities has been critical to WFBCCC’s achievement of its strategic goals. The process relies on both internal and external boards. Internationally renowned translational researcher and WFBCCC Director, Boris Pasche, MD, PhD, leads a team of eight Associate Directors who comprise his Senior Leadership team. They contribute their unparalleled expertise, vision, and strategic planning skills to mobilize the support required to bring initiatives to fruition. Senior Leadership comprises the Executive Committee, which is the primary research advisory body for WFBCCC that makes mission-critical recommendations to the WFBCCC Director for all facets of the Cancer Center related to research. It reviews the progress and future directions of the research programs, shared resources, and other components of the Cancer Center Support Grant. In addition to his Senior Leadership, Pasche relies upon the following major advisory mechanisms for input and advice: the External Advisory Board, comprised of outside experts who provide essential independent and objective evaluation and advice for the WFBCC; the Community Advisory Board, which advises the Center on effective ways to integrate community engagement into clinical, research, and educational activities, with the goal of reducing cancer burden in the catchment area; and the Internal Advisory Board, made up of Institutional leaders, which advises the Center on optimal coordination of resources and how to align Cancer Center priorities across the enterprise and the community it serves.

View original record on NIH RePORTER →